JPS63318955A - Preparation of balloon for endoscope - Google Patents

Preparation of balloon for endoscope

Info

Publication number
JPS63318955A
JPS63318955A JP62156017A JP15601787A JPS63318955A JP S63318955 A JPS63318955 A JP S63318955A JP 62156017 A JP62156017 A JP 62156017A JP 15601787 A JP15601787 A JP 15601787A JP S63318955 A JPS63318955 A JP S63318955A
Authority
JP
Japan
Prior art keywords
weight
parts
natural rubber
mold
vulcanization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62156017A
Other languages
Japanese (ja)
Other versions
JPH0233264B2 (en
Inventor
Yoshiyuki Shimamura
島村 善行
Kyogo Tsushima
恭吾 対馬
Hisato Seto
瀬戸 寿人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Okamoto Corp
M&M Co Ltd Japan
Original Assignee
Okamoto Corp
M&M Co Ltd Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okamoto Corp, M&M Co Ltd Japan filed Critical Okamoto Corp
Priority to JP62156017A priority Critical patent/JPS63318955A/en
Priority to PCT/JP1987/000825 priority patent/WO1988003005A1/en
Priority to DE19873790493 priority patent/DE3790493C2/en
Priority to GB8804231A priority patent/GB2205502B/en
Priority to EP87906945A priority patent/EP0288576B1/en
Priority to DE19873790493 priority patent/DE3790493T1/en
Publication of JPS63318955A publication Critical patent/JPS63318955A/en
Publication of JPH0233264B2 publication Critical patent/JPH0233264B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Endoscopes (AREA)

Abstract

PURPOSE:To obtain a transparent membrane main body having high strength, by compounding a small amount of a powdery vulcanizer and a powdery vulcanization promoting aid with natural rubber latex to suppress powdery additives as low as possible and adding a liquid vulcanization promoter and a liquid aging inhibitor to said latex to prepare a compounded solution and immersing mold in said solution to perform vulcanization and drying. CONSTITUTION:A compounded solution is prepared by adding 0.7-1.5pts.wt. of a powder vulcanizer, 0.2-0.5pts.wt. of a powdery vulcanization promoting aid, 0.5-1.0pts. wt. of a liquid vulcanization promoter and 0.5-1.0pts.wt. of a liquid aging inhibitor to 100pts.wt. of the rubber component of natural rubber latex. A mold is immersed in a coagulant and subsequently immersed in the compounded solution for about 30-60sec and slowly drawn up to adhere the natural rubber to the mold in a thickness of about 0.15-0.25mm and the rubber is dried at 80-90 deg.C for about 10min under heating and, after mouth binding, further vulcanized at 80-90 deg.C for about 20min under heating to form a membrane which is, in turn, demolded using a release powder. After the demolded membrane main body A is washed, said membrane main body is treated with a silicone emulsion to develop a transparent feeling and cut into a predetermined length at a mouth end part and an inflatable part 2 is provided to the tip of a fixing cylindrical part as the same body.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は血管内や管腔臓器内を、観察9診断。[Detailed description of the invention] <Industrial application field> The present invention allows observation and diagnosis of inside blood vessels and luminal organs.

治療するための内視鏡に使用するバルーン特にレーザー
光線治療に適したバルーンを製造する方法に関するもの
である。
The present invention relates to a method of manufacturing a balloon used in an endoscope for treatment, particularly a balloon suitable for laser beam therapy.

〈従来技術〉 従来此種のバルーンは無かった。<Conventional technology> Previously, there was no balloon of this kind.

血管の内に挿入し生理食塩水を注入して膨張させて血液
の流れを止めるものとしては血管用チューブカテーテル
又は動静脈留置用カテーテルがあった。これは透明なも
のではなかったが、レーザー光線を透過したり、透視し
たりすることが出来なかった。又、透明ゴム製品(例え
ば乳首)の場合は、加硫剤、加硫促進助剤に粉末のもの
を受け使用していたのでどうしても強度が落ちる傾向に
あった。そこで強度を落とさないためには、厚みを増や
すことが一般的であり、膨張することが出来ないもので
あった。
There are vascular tube catheters and arteriovenous indwelling catheters that are inserted into blood vessels and inflated by injecting physiological saline to stop the flow of blood. It wasn't transparent, but laser beams couldn't pass through it or see through it. Furthermore, in the case of transparent rubber products (for example, nipples), powdered vulcanizing agents and vulcanization accelerators have been used, which tends to reduce the strength. Therefore, in order to maintain the strength, it is common practice to increase the thickness, which prevents expansion.

〈発明が解決しようとする問題点〉 本発明は透明性を有し且つ薄くて膨張しても強度を満し
レーザー光線を透過することが出来る内視鏡用バルーン
を提供するものである。
<Problems to be Solved by the Invention> The present invention provides an endoscopic balloon that is transparent, thin, and strong even when expanded, and can transmit laser beams.

〈問題点を解決するための手段〉 本発明は上記事情に鑑みてなされたもので、天然ゴムラ
テックスに粉末加硫剤と粉末加硫促進助剤を少量配合し
て粉末添加剤をできる限り抑え、液状加硫促進剤と液状
老化防止剤とを添加した配合溶液に成形型を浸漬するも
のである。
<Means for Solving the Problems> The present invention was made in view of the above circumstances, and consists of blending a small amount of powdered vulcanizing agent and powdered vulcanization accelerator into natural rubber latex to suppress the amount of powdered additives as much as possible. , the mold is immersed in a mixed solution containing a liquid vulcanization accelerator and a liquid anti-aging agent.

〈実施例〉 本発明の実施の一例を説明すると配合溶液は天然ゴムラ
テックスのゴム分100重量部に対して、粉末加硫剤0
.7〜1.5重石部好ましくは0.8〜1.2重61部
、粉末加硫促進助剤0,2〜0.5ffl 置部好まし
くは0.3〜0.4重量部と、液状加硫促進剤0.5〜
1.0重量部、液状老化防止剤0.5〜1.0重量部を
添加してなるもので、その配合方法は分散した加硫剤及
び加硫促進助剤を天然ゴムラテックスに添加し、混合撹
拌した後、加硫促進剤および老化防止剤を添加し、10
〜15℃の恒温槽中に12〜24時間放置した後、更に
25〜35℃の恒温槽中で24〜48時間放置して熟成
させる。
<Example> To explain an example of the implementation of the present invention, the blended solution contains 0 parts by weight of powder vulcanizing agent for 100 parts by weight of the rubber content of natural rubber latex.
.. 7 to 1.5 parts by weight, preferably 61 parts by weight, 0.8 to 1.2 parts by weight, 0.2 to 0.5 ffl powder vulcanization accelerator, preferably 0.3 to 0.4 parts by weight, and liquid vulcanization. Sulfur accelerator 0.5~
It is made by adding 1.0 parts by weight and 0.5 to 1.0 parts by weight of a liquid anti-aging agent, and its compounding method is to add dispersed vulcanizing agents and vulcanization accelerators to natural rubber latex, After mixing and stirring, vulcanization accelerator and anti-aging agent were added, and 10
After being left in a constant temperature bath at ~15°C for 12 to 24 hours, it is further left in a constant temperature bath at 25 to 35°C for 24 to 48 hours to ripen.

成形型は所定の大きさ、形状をした本体を得るためのい
わゆる浸漬製造型であり、この成形型を凝固剤に浸漬し
てから前記配合溶液に30〜60秒間程度浸漬した後、
ゆっくり引き揚げて天然ゴムを0.15〜0.25蔵程
度附着さじ、80〜90℃で10分間程度加熱乾燥した
後口1巻きし、更に80〜90’Cで20分間程度加熱
加硫して薄膜状とし、剥離粉などを用いて脱型し、この
型を洗浄、乾燥して再度、初めの凝固剤に浸漬させこれ
を繰り返し行なうものである。
The mold is a so-called immersion manufacturing mold for obtaining a main body with a predetermined size and shape, and after immersing this mold in a coagulant and then immersing it in the mixed solution for about 30 to 60 seconds,
Slowly pull up natural rubber and apply 0.15 to 0.25 degrees of natural rubber, heat and dry at 80 to 90 degrees Celsius for about 10 minutes, wrap it around once, and then heat and vulcanize it at 80 to 90 degrees Celsius for about 20 minutes. The mold is formed into a thin film, removed from the mold using release powder, etc., and the mold is washed, dried, and immersed in the original coagulant again, and this process is repeated.

脱型したa膜状本体は洗浄した後、シリコーンエマルジ
ョン処理して透明感を出し、80℃で60分程度乾燥せ
しめ所定の長さに口元カッティングを行う。この透明薄
膜本体は、固定筒部の先に伸縮自在で膨張可能な膨脹部
を同一体に設けたもので、固定部は一方端を開放状とし
た内径0.90〜17.00.程麿の略円筒形状をして
おり、膨脹部から透視し、内視鏡に形成しであるチャン
ネル又は送気送水口から生理食塩水を注入することによ
って、透明性膨脹部を所定の大きさに膨張する球状体又
は膨出体或いは筒状体である。このllillli部は
前記固定筒部より大径状に形成するか、小径状又は同径
状とするかは任意であり、又は膨脹部と固定筒部との間
に小径状のくびれ部又は補強凸条リングを同一体に設け
ることも可能である。その内径も0.80〜35.0a
at程度と診断や治療する場所に応じて適宜大きさのも
のを選び、いずれにしても生理食塩水の注入によって膨
張し薄膜がさらに薄くなって透視が一層よくなると共に
レーザー光線が透過出来るものである。
The demolded a-film body is washed, treated with silicone emulsion to give it a transparent feel, dried at 80° C. for about 60 minutes, and cut at the mouth to a predetermined length. This transparent thin film main body has a fixed cylindrical part and an extensible and expandable part disposed in the same body, and the fixed part has an open end at one end and has an inner diameter of 0.90 to 17.00 mm. It has a roughly cylindrical shape, and by looking through the inflatable part and injecting physiological saline through a channel or air supply port formed in the endoscope, the transparent inflatable part can be adjusted to a predetermined size. It is a spherical body, a bulging body, or a cylindrical body that expands. This llilli portion may be formed to have a larger diameter than the fixed cylindrical portion, a smaller diameter, or the same diameter as the fixed cylindrical portion, or a small diameter constriction or a reinforcing convex portion between the expansion portion and the fixed cylindrical portion. It is also possible to provide the strip rings in one piece. Its inner diameter is also 0.80~35.0a
An appropriate size is selected depending on the degree of AT and the location to be diagnosed and treated, and in any case, it expands when saline is injected, making the thin film even thinner, improving fluoroscopy and allowing laser beams to pass through.

具体的実施の態様 天然ゴムラテックス(ポリ−164−イソプレン)ゴム
分 100重聞部 粉末加硫剤(コロイド硫黄)1.2重量部粉末加硫促進
助剤(all化亜鉛)    0.35重a部加硫促進
剤(ジチオカルバメート系)0.7重石部老化防止剤(
パラフィンエマルジョン)1.0重量部 からなる配合溶液を用いる。
Specific implementation mode Natural rubber latex (poly-164-isoprene) Rubber content 100 parts by weight Powder vulcanizing agent (colloidal sulfur) 1.2 parts by weight Powder vulcanization accelerator (allium oxide) 0.35 parts by weight Part vulcanization accelerator (dithiocarbamate type) 0.7 weight part Anti-aging agent (
A blended solution consisting of 1.0 parts by weight of paraffin emulsion is used.

成形型を10%硝酸カルシウム・メタノールを添加せる
室温の凝固剤溶液にゆっくり浸漬して直ちにゆっくり引
き揚げた後、前記配合溶液にゆっくり浸漬して室温で3
0〜60秒後ゆっくり引き揚げ、天然ゴムを耐着させ8
0℃で10分間乾燥し口巻きした後90℃で20分間加
熱加硫して、膜厚が0.16m、内径が1.94 Mの
固定筒部と、その先に膜厚が0.22 M、内径が1.
54111iのくびれ部を介して膜厚が0.16mm、
内径が1.81 mtaの球状1服部が同一体で、かつ
膨脹部の頂面の膜厚が0.19履となった薄膜状物とし
、該薄膜状物を剥離粉を用いて脱型して0.5%アンモ
ニア水で約16時間洗浄後、10%シリコンエマルジョ
ンに室温でまんべんなくつけ80℃で60分間乾燥し透
明感のすぐれた透明性薄膜本体を得た。
The mold was slowly immersed in a coagulant solution containing 10% calcium nitrate/methanol at room temperature, immediately pulled up slowly, and then slowly immersed in the above-mentioned mixed solution for 3 hours at room temperature.
After 0 to 60 seconds, slowly lift it up and let the natural rubber adhere to it.8
After drying at 0°C for 10 minutes and wrapping, heat and vulcanize at 90°C for 20 minutes to form a fixed cylinder with a film thickness of 0.16 m and an inner diameter of 1.94 M, and a film thickness of 0.22 m at the tip. M, inner diameter is 1.
The film thickness is 0.16 mm through the constriction of 54111i,
The spherical parts with an inner diameter of 1.81 mta were made into a thin film-like product with a uniform body and a film thickness of 0.19 mm on the top surface of the expanded part, and the thin film-like product was demolded using release powder. After washing with 0.5% ammonia water for about 16 hours, it was soaked evenly in a 10% silicone emulsion at room temperature and dried at 80°C for 60 minutes to obtain a transparent thin film body with excellent transparency.

以上の様に浸漬成形した透明性薄膜本体<A)は上記寸
法、肉厚に限定されるものではなく第1図乃至第4図に
示す如く固定筒部(1)の先部に膨脹部(2)を同一体
に形成し必要に応じて両者(1)(2)間にくびれ部(
3)又は凸条リング(4)を設けた任意形態及び寸法、
肉厚のものであり、この本体(A)を第5図に示す如く
内視鏡(B)の先端部(b)に固定して膨脹部が突出す
るように取付ける。内祝1(B)の先端部(b)は第6
図に示す如く、2本のライトガイド(b−1)(b−1
) 、対物レンズ(b−2)、処置具、治療具、鉗子な
どを挿入するチャンネル(b−3)、送気送水口(b−
4)などをイ1し、上下左右方向に自由に動かすことが
出来るようになっているところの周知の構造のものであ
る。このような内視鏡(B)の先端部(b)に前述の本
体(Δ)を被覆取付けた後、血管内や管腔臓器(食道、
胃・−二脂腸、大腸。
The transparent thin film body <A) dip-molded as described above is not limited to the above-mentioned dimensions and wall thickness, but as shown in Figs. 2) are formed into the same body, and if necessary, a constriction part (
3) or any form and size provided with a convex ring (4),
This main body (A) is fixed to the distal end (b) of an endoscope (B) as shown in FIG. 5, and is attached so that the inflatable part protrudes. The tip (b) of the family celebration 1 (B) is the 6th
As shown in the figure, two light guides (b-1) (b-1
), objective lens (b-2), channel for inserting treatment instruments, treatment instruments, forceps, etc. (b-3), air and water supply port (b-
4) etc., and is of a well-known structure that can be freely moved up, down, left and right. After attaching the above-mentioned main body (Δ) to the distal end (b) of such an endoscope (B), it is possible to inspect the inside of blood vessels and luminal organs (esophagus, esophagus, etc.).
Stomach, bifatty intestine, large intestine.

の咽腔、胆道、腹腔、膀胱、子宮脛部なと)内に挿入し
て、内視&Q(B)のチャンネル(b−3)又は送気送
水口(b−4)から生理食塩水を注入し膨脹部(2)を
膨張ぎりで、出血部位や病巣などの患部を観察又は診断
し、チャンネル(b−3)に光ファイバー(b−s)を
挿入してレーザー光線を照射して治療するものである。
(pharynx, biliary tract, abdominal cavity, bladder, uterine shin, etc.) and inject physiological saline through the endoscopy & Q (B) channel (b-3) or the air and water supply port (b-4). Inject it, expand the inflatable part (2) to its fullest extent, observe or diagnose the affected area such as a bleeding site or lesion, and treat it by inserting an optical fiber (bs) into the channel (b-3) and irradiating it with a laser beam. It is.

このようにして使用するため本体(A)、特に膨張した
際の膨脹部(2)が不透明であると患部が不鮮明で見落
す危険性があり、さらにレーザー光線を照射するため不
透明の場合はレーザー光線の透過性が悪くなるため治療
効果が向上しないのみならずエネルギーが本体に吸収さ
れ、本体の耐久性をも縮めてしまうものであり、本体は
a肌性と透明性との双方を有するものでなければならな
い。
Because it is used in this way, if the main body (A), especially the expansion part (2) when expanded, is opaque, there is a risk of the affected area being unclear and being overlooked.Furthermore, since the laser beam is irradiated, if the body (A) is opaque, there is a risk of overlooking the affected area. Not only does the therapeutic effect not improve due to poor permeability, but also energy is absorbed into the main body, reducing the durability of the main body, so the main body must have both skin properties and transparency. Must be.

く効 果〉 本発明は天然ゴムラテックスのゴム分100重足部に対
し、粉末加硫剤011〜1.5重は部、粉末加硫促進助
剤0.2〜0.5重量部、液状加硫促進剤0.5〜1.
0重ω部、液状老化防止剤0.5〜1.0重Ld部を添
加した配合溶液に、成形型を浸漬して加硫乾燥してなる
から、透明性があってしかも強度が大である薄膜本体が
得られる。
Effectiveness> The present invention uses 0.1 to 1.5 parts by weight of a powder vulcanizing agent, 0.2 to 0.5 parts by weight of a powder vulcanization accelerator, and a liquid Vulcanization accelerator 0.5-1.
The mold is immersed in a mixed solution containing 0 parts by weight ω and 0.5 to 1.0 parts by weight Ld of a liquid anti-aging agent and vulcanized and dried, so it is transparent and has great strength. A thin film body is obtained.

又この透明性薄膜本体を内視鏡の先端部に取付けること
によって、ライトガイドや対物レンズ或いは光ファイバ
ーに血液や分泌物1食物などが耐着せず、患部が見ずら
くならず、診断や治療が充分行い得ると共に、生理食塩
水の注入によって膨脹部が容易に膨らみ、これによって
所定の空間部が出来、視野を広げ、患部の観察及び診断
或いは治療がさらに一層確実に行い得る。例えば、血栓
病等の病巣を診断し、又、病巣にレーザー光線を照射し
て治療したり、或いは食道静脈瘤の病巣又は胃・−二脂
腸の病巣などを圧迫して出血をおさえ、止血uしめたり
、若しくは狭窄した部分を拡開し治療することが出来る
。その他各臓器においても患部に光ファイバーを透過す
るヤグレーザ−。
In addition, by attaching this transparent thin film body to the tip of the endoscope, blood, secretions, food, etc. will not adhere to the light guide, objective lens, or optical fiber, and the affected area will not be difficult to see, making diagnosis and treatment easier. In addition, the inflatable part can be easily inflated by injecting physiological saline, thereby creating a predetermined space, widening the field of view, and making it possible to observe and diagnose or treat the affected area more reliably. For example, we can diagnose the focus of thrombotic disease, treat the focus by irradiating the focus with a laser beam, or apply pressure to the focus of esophageal varices or the focus of the stomach or diabetic intestine to control bleeding and stop the bleeding. It can be treated by tightening or widening the narrowed area. YAG laser transmits optical fibers to affected areas in other organs as well.

アルゴンレーザー、アルゴンダイレーザーなどのレーザ
ー光線を照射して出血を止めたり寓病巣を焼灼したりし
て治療することも出来、新しい治療法の提供に役立つも
のである。
It can also be treated by irradiating laser beams such as argon laser or argon dye laser to stop bleeding or cauterize the lesion, which is useful in providing new treatment methods.

しかも血管内において使用する場合には、膨脹部を膨ら
まVることによって血管の内面に密接し、血液の流れを
止めることが出来るため、従来のように、内視鏡挿入個
所とは別の個所を切開する事がなく、カテーテルのよう
な部材も不要となり治療も容易となるものである。
Moreover, when used inside a blood vessel, the inflatable part can be inflated and brought into close contact with the inner surface of the blood vessel to stop the blood flow. There is no need to make an incision, and there is no need for a member such as a catheter, making treatment easier.

【図面の簡単な説明】[Brief explanation of drawings]

図面は本発明の製造方法によって製造された透明性薄膜
本体を示すもので、第1図は縦断正面図、第2図乃至第
4図は他の実施例の縦断正面図、第5図は内視鏡に取付
けた状態図、第6図は内視鏡の先端部の拡大図、第7図
は血管内に挿入した使用状態の拡大図であり、(A)は
本体、(1)は筒状固定部、(2)はi脹部である。
The drawings show a transparent thin film body manufactured by the manufacturing method of the present invention, in which FIG. 1 is a longitudinal sectional front view, FIGS. 2 to 4 are longitudinal sectional front views of other embodiments, and FIG. 5 is an interior view. Fig. 6 is an enlarged view of the distal end of the endoscope, and Fig. 7 is an enlarged view of the endoscope in use when inserted into a blood vessel. (A) is the main body, (1) is the tube. The shaped fixation part (2) is the i-bulge part.

Claims (1)

【特許請求の範囲】[Claims] 天然ゴムラテックスのゴム分100重量部に対し、粉末
加硫剤0.7〜1.5重量部、粉末加硫促進助剤0.2
〜0.5重量部、液状加硫促進剤0.5〜1.0重量部
、液状老化防止剤0.5〜1.0重量部を添加して配合
溶液を構成し、この溶液に成形型を浸漬して天然ゴムを
附着させ、加硫乾燥後、脱型し、筒状固定部の先に膨脹
部を同一体に形成した透明性薄膜本体からなる内視鏡用
バルーンの製造方法。
0.7 to 1.5 parts by weight of powder vulcanizing agent and 0.2 parts by weight of powder vulcanization accelerator for 100 parts by weight of rubber content of natural rubber latex.
~0.5 parts by weight, 0.5 to 1.0 parts by weight of a liquid vulcanization accelerator, and 0.5 to 1.0 parts by weight of a liquid anti-aging agent are added to form a compounded solution, and a mold is added to this solution. A method for producing an endoscopic balloon consisting of a transparent thin film body, which is dipped in natural rubber to adhere natural rubber, vulcanized and dried, and then demolded to form an inflatable part at the end of a cylindrical fixing part.
JP62156017A 1986-10-29 1987-06-22 Preparation of balloon for endoscope Granted JPS63318955A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP62156017A JPS63318955A (en) 1987-06-22 1987-06-22 Preparation of balloon for endoscope
PCT/JP1987/000825 WO1988003005A1 (en) 1986-10-29 1987-10-27 Ballon for endoscope or optical fiber and production method thereof
DE19873790493 DE3790493C2 (en) 1986-10-29 1987-10-27 Balloon for endoscope or optical fibre - is made of rubber to protect light guides, etc. from body fluids, etc.
GB8804231A GB2205502B (en) 1986-10-29 1987-10-27 Balloon endoscopy
EP87906945A EP0288576B1 (en) 1986-10-29 1987-10-27 Balloon for endoscope
DE19873790493 DE3790493T1 (en) 1986-10-29 1987-10-27 ENDOSCOPE OR BALLOON FOR USING AN OPTICAL FIBER AND METHOD FOR PRODUCING THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62156017A JPS63318955A (en) 1987-06-22 1987-06-22 Preparation of balloon for endoscope

Publications (2)

Publication Number Publication Date
JPS63318955A true JPS63318955A (en) 1988-12-27
JPH0233264B2 JPH0233264B2 (en) 1990-07-26

Family

ID=15618492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62156017A Granted JPS63318955A (en) 1986-10-29 1987-06-22 Preparation of balloon for endoscope

Country Status (1)

Country Link
JP (1) JPS63318955A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0213423A (en) * 1988-06-30 1990-01-17 Okamoto Ind Inc Balloon for catheter and manufacture thereof
JP2015505678A (en) * 2011-09-22 2015-02-26 ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity System and method for visualizing ablated tissue

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0213423A (en) * 1988-06-30 1990-01-17 Okamoto Ind Inc Balloon for catheter and manufacture thereof
JP2015505678A (en) * 2011-09-22 2015-02-26 ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity System and method for visualizing ablated tissue

Also Published As

Publication number Publication date
JPH0233264B2 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
US5029574A (en) Endoscopic balloon with a protective film thereon
US4597762A (en) Collagen preparation
RU2380054C2 (en) Flexible and rigid resector spray can with catheter
CA2448900C (en) Method and apparatus for sealing access
US20060004408A1 (en) Method and apparatus for sealing access
AU2002310364A1 (en) Method and apparatus for sealing access
JP4675414B2 (en) Organ model
CN113181427B (en) In vivo in situ biological manufacturing method and application thereof in vivo tissue repair
EP0288576B1 (en) Balloon for endoscope
JPS63318955A (en) Preparation of balloon for endoscope
CN208145032U (en) It is implanted into the device of the abnormal swelling part of ductus arteriosus wall
JPH02111373A (en) Manufacture for balloon
JPS6122981B2 (en)
CN207785590U (en) Medical cavity scope punctures impregnator
JPH034243Y2 (en)
CN107007316A (en) It is implanted into the device of the abnormal swelling part of ductus arteriosus wall
JPH0213423A (en) Balloon for catheter and manufacture thereof
EP3300057B1 (en) Use of a simulated animal organ
JPH0340244Y2 (en)
JPH0327601Y2 (en)
JPH0327602Y2 (en)
JPH0151264B2 (en)
JPH034242Y2 (en)
JPS63315025A (en) Balloon for endoscope
JPH0337928B2 (en)